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Patients with chronic kidney disease have high rates of
myocardial infarction and death following an initial attack.
Proximal location of coronary atherosclerotic lesions has
been linked to the risk of acute myocardial infarction and to
infarction-associated mortality. To examine if the spatial
distribution of lesions differs in patients with and without
chronic kidney disease, we used quantitative coronary
angiography to measure this in patients with acute coronary
thromboses who were having angiography following acute
myocardial infarction. Multivariable linear regression was
used to adjust for differences in baseline characteristics.
Among 82 patients with stage 3 or higher chronic kidney
disease, 55.6% of lesions were located within 30 mm and
87.7% were within 50 mm of the coronary ostia. This
compared to 34.7 and 71.8%, respectively, among 299
patients without significant kidney disease. Chronic kidney
disease was independently and significantly associated with
a 7.0 mm decrease in the distance from the coronary ostia to
the problem lesion. Our study suggests that a causal link
between a more proximal culprit lesion location in patients
with chronic kidney disease and their high mortality rates
after myocardial infarct is possible and may have important
implications for interventions to prevent infarction.
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Individuals with chronic kidney disease (CKD) suffer from
high rates of myocardial infarction (MI) and cardiovascular
death1 and suffer from high rates of death following MI2
compared to individuals with normal renal function.
Systemic factors such as inflammation and oxidative stress
have been implicated in the etiology of this increased risk and
have been the focus of numerous investigations,3–5 but
whether patients with CKD have a unique anatomic patters
of atherosclerosis and plaque rupture remains undetermined.
In the general population, the location of MI has been
measured. Coronary thromboses leading to MI are distrib-
uted in a nonuniform manner. They cluster within the
proximal one-third of the coronary arteries, and the
likelihood of clinically significant plaque rupture decreases
by 13–30% for each 10 mm away from the coronary artery
ostia.6,7 Clinical outcomes following plaque rupture are also
profoundly influenced by plaque location. In ST elevation
MI, for example, the risk of death following acute plaque
rupture is low when thromboses are distal, but doubles when
thromboses occur proximally.8–10
These studies suggest that both the risk of MI and its
clinical severity are closely linked to plaque location and vary
inversely with distance away from the coronary artery
ostium. Differences in the spatial distribution of culprit
lesions for MI might partly explain CKD-related differences
in both the risk of MI and the risk of death following MI. We
sought to identify differences in MI location between patients
with and without CKD.
RESULTS
Baseline characteristics
In total, 381 patients, 198 (52.0%) with ST elevation MI
(STEMI) and 183 with non-ST elevation MI (NSTEMI)
(48.0%) met the inclusion criteria and underwent quantita-
tive angiographic analysis using standardized angiographic
views of each coronary segment (Table 1). Mean estimated
glomerular filtration rate (eGFR) was 80.0±27.7 ml/min per
1.73 m2, and 82 (21.5%) patients had an eGFRo60 ml/min
per 1.73 m2. In all, there were 133 patients with normal renal
function/class 1 CKD, 166 patients with class 2 CKD, and 69
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patients with class 3 CKD. Of 13 patients with class 4/5 CKD,
3 were on chronic dialysis. Distribution of eGFR is shown in
Figure 1.
Individuals with stage 3 or higher CKD were older (72.5
years vs 60.7 years) more likely to be women (52.2 vs 27.4%),
and they were more likely to have diabetes (41.5 vs 22.4%),
dyslipidemia (72.0 vs 55.2%), or a prior history of MI (31.7
vs 14.7%). STEMI was less common in individuals with stage
3 or higher CKD (30.5 vs 58.9%) and left main artery infarct
location was more common (6.1 vs 1.0%). Other MI
characteristics did not differ by CKD class. Patient char-
acteristics are summarized in Table 2.
Overall lesion characteristics
Median distance to lesion (DTL) for the entire cohort was
35.3 mm. Lesions were more frequently located in the left
anterior descending (LAD) or diagonal vessels (N¼ 140) and
the right coronary (RCA; N¼ 145) than in other vessels. Left
main (N¼ 8) and ramus intermedius vessels (N¼ 5) were
infrequent sites of acute thrombosis. Thromboses in the RCA
were more distal than lesions in other coronary arteries
(Po0.001) whereas left main lesions were significantly more
proximal (Po0.002). Distribution of lesions according to
vessel and CKD status is shown in Table 3.
Lesion location
On univariate analysis (Table 4), male patients (b¼ 8.18,
Po0.001), patients with STEMI (b¼ 8.58, Po0.001), and
patients with an RCA infarct (b¼ 11.78, Po0.001) had more
distal lesions. Patients with diabetes (b¼5.78, Po0.001),
stage 3 or higher CKD (b¼10.21, Po0.001), left main
infarct or LAD infarcts had more proximal lesions. Lesion
location was not associated with peak CK or ejection fraction,
but patients with congestive heart failure did have more
proximal lesions (b¼7.11, P¼ 0.05) than patients without
heart failure. Overall DTL was closely related to the stage of
CKD with lower distances observed in more advanced stages of
CKD (P for trendo0.001). Mean (s.d.) DTL was 43.3 (25.1) in
patients with no CKD/class 1 CKD, 41.3 (24.0) in class 2 CKD,
32.5 (24.0) in class 3 CKD, and 29.7 (15.6) in class 4/5 CKD.
When the major vessels were examined individually
(vessel analysis), patients with stage 3 or higher CKD had
more proximal lesions in the left circumflex (LCX; 19.6 vs
27.6, P¼ 0.06) and the RCA (34.5 vs 50.2, P¼ 0.02), but not
in the LAD (19.4 mm vs 21.5, P¼ 0.43). In patients with
CKD, 55.6% of lesions were located within 30 mm and 87.7%
were located within 50 mm of the coronary ostia (left main
analysis). Conversely, in patients without stage 3 or higher
CKD, only 34.7% of lesions were located within 30 mm and
only 71.8% were located within 50 mm of the coronary ostia.
Unadjusted associations of CKD with lesion location are
shown in Figures 2 and 3.
Chronic kidney disease remained a significant predictor of
DTL after adjustment for age, sex, race, diabetes, hyper-
tension, smoking, hyperlipidemia, infarct vessel, and family
history of coronary artery disease (Table 5). Stage 3 or higher
CKD was independently associated with a 7.0 mm more
proximal MI location (95% confidence interval (CI):
13.39–0.61, P¼ 0.03) compared to patients without CKD.
Conversely RCA lesions and male sex were associated with
adjusted increases of 10.54 mm (95% CI: 5.14–15.94,
Po0.001) and 7.31 mm (95% CI: 2.05–12.58, P¼ 0.01),
respectively. The association of CKD with DTL was similar in
diabetics vs nondiabetics (P for interaction 0.18), STEMI vs
NSTEMI (P for interaction 0.23) and men vs women (P for
interaction 0.30). The adjusted association of CKD with DTL
was not significantly different in patients with LAD infarcts
compared to those with infarcts in other vessels (P for
interaction 0.18).
Secondary analyses using the stages of CKD in place of the
binary definition of CKD revealed a trend toward shorter
DTL in patients with more advanced stages of CKD. Results
were qualitatively similar regardless of the serum creatinine
used to estimate eGFR (Table 6).
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Figure 1 | Distribution of estimated glomerular filtration rate
in the study population. CKD was defined as estimated GFR
o60 ml/min per 1.72 m2. Using this definition 82 of the
population of 381 (21.5%) had CKD.
Table 1 | Angiographic projections used in individual
coronary artery segments
Segment Projection
Left main artery Anterior posterior caudal
Ramus intermedius Left anterior oblique cranial
Right coronary artery —
Proximal Straight left anterior oblique
Mid Straight left anterior oblique
Distal Straight left anterior oblique
Posterior descending artery Left anterior oblique cranial
Posterior lateral segment Left anterior oblique cranial
Left anterior descending artery —
Proximal Right anterior oblique caudal
Mid Right anterior oblique caudal
Distal Right anterior oblique caudal
First diagonal Left anterior oblique cranial
Second diagonal Left anterior oblique cranial
Circumflex artery —
Proximal Right anterior oblique caudal
Mid Right anterior oblique caudal
Distal Right anterior oblique caudal
First obtuse marginal Right anterior oblique caudal
Second obtuse marginal Right anterior oblique caudal
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DISCUSSION
Patients with CKD suffer from both a high incidence of MI
and a high risk of death following initial MI,1,2 but the
etiology of this remains incompletely understood. Differences
in the distribution and location of coronary artery plaque
ruptures in individuals with CKD compared to those without
CKD could partly explain this increased risk, but has not
been previously examined. We therefore compared the
distribution of acute coronary thromboses in patients with
and without CKD who were undergoing angiography for
acute MI. We found that the lesions accounting for acute MI
were, on average, significantly more proximally distributed in
patients with stage 3 or higher CKD than in patients without
CKD and that this difference was independent of comorbid
conditions such as diabetes and hypertension.
Proximal culprit lesions are known to be significantly
associated with an increased risk of death or major
complications following an MI. In an analysis of STEMI
patients undergoing thrombolysis, Karha et al.9 found that
the risks of in-hospital death or recurrent MI were twofold
higher when the culprit lesion was located proximal to the
first major branch vessel of an epicardial artery. Within the
LAD, the odds ratio of 30-day death or MI decreased by 0.79
for each 1 cm increase in distance down the artery. In a
similar analysis of patients undergoing primary percutaneous
intervention for acute MI, the adjusted odds of in-hospital
Table 2 | Baseline characteristics of the study population
Characteristic Chronic kidney disease (N=82) Normal kidney function (N=299) P-value
Demographics
Age, mean±s.d. 72.5±11.3 60.7±12.0 o0.001
Male sex 40 (48.8) 215 (72.6) o0.001
Race
White 70 (85.4) 249 (83.3) 0.65
Black 6 (7.3) 24 (8.0) 0.83
Medical history
Diabetes 34 (41.5) 67 (22.4) 0.001
Dyslipidemia 59 (72.0) 165 (55.2) 0.01
Hypertension 73 (89.0) 197 (65.9) o0.001
Present smoking 6 (7.3) 97 (32.4) o0.001
Past smoking 24 (29.3) 78 (26.1) 0.56
Prior MI 26 (31.7) 44 (14.7) o0.001
Family history of coronary artery disease 20 (24.4) 116 (38.8) 0.02
Laboratory data
Creatinine, median (IQR), (mg per 100 ml) 1.4 (1.3–1.7) 0.90 (0.8–1.0) o0.001
Estimated GFR, median (IQR), (ml/min per 1.73 m2) 44.8 (37.2–53.3) 87.2 (75.0–102.8) o0.001
Ejection fraction, mean±s.d., (%) 46.3±12.2 47.6±11.8 0.45
Peak CK, median (IQR), (IU/l) 395 (142–1360) 492 (175–1128) 0.57
Infarct characteristics
ST elevation MI 25 (30.5) 173 (58.9) o0.001
Infarct location 0.04
Left main 5 (6.1) 3 (1.0) —
LAD 29 (35.4) 111 (37.1) —
LCX 19 (23.2) 64 (21.4) —
RCA 27 (32.9) 118 (39.5) —
Ramus 2 (2.4) 3 (1.0) —
CHF on presentation 13 (15.9) 36 (12.0) 0.12
MI, myocardial infarction; IQR, interquartile range; GFR, glomerular filtration rate; CK, chronic kidney; LAD, left anterior descending; LCX, left circumflex; RCA, right coronary;
CHF, congestive heart failure.
Table 3 | Distance to lesion in millimeters from coronary ostia
Location of occlusion CKD (N=81) No CKD (N=299) P-value
Overalla, median (IQR) 28.4 (12.0–41.0) 37.2 (12.7–51.6) o0.001
Left main, median (IQR) 13.6 (12.0–24.7) 7.3 (6.8–28.0) 0.46
Left anterior descending, median (IQR) 19.4 (11.7–28.7) 21.5 (14.1–32.7) 0.43
Left circumflex, mean±s.d. 19.6±14.9 27.6±17.0 0.06
Right coronary artery, mean±s.d. 34.5±19.3 50.2±31.4 0.02
Ramus, mean±s.d. 7.0±3.6 12.0±5.6 0.31
CKD, chronic kidney disease; IQR, interquartile range.
aOverall distance to lesion is measured in millimeters from the ostium of the right coronary artery for right coronary lesions and from the ostium of the left main for all other
lesions. In the individual coronary arteries distance to lesion is measured from the ostium of each artery.
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mortality was more than 1.5-fold higher in patients with
proximal lesions compared to those with more distal lesions.
The presence of proximal culprit lesions was independently
associated with the risk of ventricular arrhythmias or
sustained hypotension during the initial hospitalization and
demonstrated a strong trend toward an increased risk of
major adverse cardiovascular events during the first year
following MI.10
Within the context of this strong association between the
risk of death or recurrent MI and the location of the culprit
lesion responsible for acute MI, our findings of a significant
difference in the spatial distribution of culprit lesions in
individuals with and without CKD suggests that spatial
distribution of coronary lesions may be an important
determinant of the high risk of death following MI in
patients with CKD. Indeed, if the relative risk of death in
patients with proximal culprit lesions is truly 1.5- to 2.0-fold
higher9,10 than in patients with nonproximal lesions, then the
15.9% increase in the percentage of lesions located within the
proximal 50 mm of the coronary tree that we observed in
individuals with CKD compared to those without CKD could
potentially account for a substantial portion of the increased
risk of death in patients with CKD. Our findings argue for the
addition of proximal culprit lesion location to the growing
list of risk factors and risk markers that have been associated
with the post-MI mortality in patients with CKD. Although
lesion location as a risk factor does not suggest a particular
pharmacologic intervention as do dyslipidemia, inflamma-
tion, and oxidative stress, there are nevertheless potentially
important therapeutic implications to our findings. Because
the proximal coronary tree is more likely to contain culprit
lesions for MI, this region can be considered to be an
anatomically high-risk region that could potentially be
targeted for preemptive interventions to prevent MI.
In fact, the high risks of cardiovascular death in patients
with CKD,1,2 the uncertain benefit of standard medical
therapies in this population,11,12 and the more proximal
distribution of plaque ruptures in patients with CKD suggest
that the CKD population may be a particularly attractive
group in which to investigate novel medical or interventional
therapies designed to target anatomic regions at higher risk of
plaque rupture. Natural history studies of proximal athero-
sclerotic lesions in patients with CKD, as well as studies
Table 4 | Crude associations with distance to lesion
Variable b P-value
Demographics — —
Age — —
o40 9.17 0.22
40–59 1.57 0.54
60–79 Referent Referent
X80 3.85 0.39
Male sex 8.18 0.001
Race — —
White Referent Referent
Black 4.35 0.33
Other 0.95 0.83
Medical history
Diabetes 5.78 0.03
Dyslipidemia 3.61 0.17
Hypertension 1.58 0.55
Present smoking 4.82 0.08
Past smoking 1.25 0.65
Prior MI 2.30 0.46
Family history of CAD 4.64 0.06
CKD 10.21 o0.001
Laboratory data — —
Estimated GFR (per 10 ml/min per 1.73 m2) 1.20 0.01
Ejection fraction, (per 10%) 1.45 0.21
Peak CK, (per 1 U/l) 0.00 0.67
Infarct characteristics
ST elevation MI 8.58 o0.001
Infarct vessel
Left main 25.53 0.002
Left anterior descending 7.22 0.004
left circumflex 2.33 0.43
Right coronary artery 11.78 o0.001
Ramus 14.85 0.16
CHF on presentation 7.11 0.05
MI, myocardial infarction; CAD, coronary artery disease; CK, chronic kidney; GFR,
glomerular filtration rate; CHF, congestive heart failure.
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Figure 2 | Infarct location in patients with and without CKD. (a) Frequency distribution and (b) cumulative frequency distribution.
Kidney International (2009) 75, 80–87 83
DM Charytan et al.: Proximal location of MI in CKD o r i g i n a l a r t i c l e
analyzing the role of lesion location as an adjunct to the
measurement of established risk factors in cardiovascular
risk-stratification tools should help determine whether
pursuing such novel approaches to the prevention of MI
are warranted.
Our findings should be interpreted within the context of
the study design. The relatively small sample size limited our
ability to analyze for differences in DTL according to stage of
CKD or infarct vessel. Nevertheless, our analysis suggested
that higher stages of CKD are associated with progressively
more proximal coronary occlusions, and that the association
of CKD with DTL was more pronounced in the LCX and
RCA than in the LAD. However, the CIs around these
estimates were wide, and the mean DTL in the LAD remained
lower in patients with CKD than in those without CKD.
Furthermore, the adjusted interaction between CKD and
LAD infarct location was nonsignificant. Thus, larger studies
with greater power to perform subgroup and stratified
analyses are needed to refine our estimates of the relationship
between CKD, DTL, and infarct vessel.
Estimates of renal function have an imperfect correlation
with true GFR. In this study, a single serum creatinine was
used to define CKD status, and although all samples were
analyzed by a single laboratory, serum creatinine was not
calibrated against the Cleveland Clinic Laboratory.13
Although some misspecification of CKD status may have
occurred, our results were qualitatively unchanged when an
alternative creatinine was used to estimate eGFR. Further-
more, misclassification of CKD status would most likely have
been nondifferential with respect to culprit lesion location,
and misclassification of renal function is thus unlikely to
fully explain our finding of a positive association
between CKD and lesion location. An additional concern is
that angiography was used to assess distance from
coronary ostia to culprit lesions. Future studies should
consider using intravascular ultrasound to assess DTL as this
technique may be more accurate than angiography in
measuring absolute distances. However, intravascular
ultrasound is a time-consuming, invasive technique. Its use
to measure DTL would have delayed intervention on the
acute coronary occlusions we studied and would not
have been feasible in all cases, particularly in the setting of
STEMI. Standardized angiographic views were used to
minimize foreshortening, and foreshortening effects should
have been similar in both groups. Nevertheless, it is possible
that our methods have underestimated the true DTL in some
patients.
Finally, we cannot exclude the possibility that the
differences in DTL were confounded by differential referral
of patients with and without CKD for coronary angiography.
If patients with CKD are referred for coronary angiography
only when MI is clinically severe, then the more proximal
distribution that we observed could be a surrogate for MI
severity rather than a consequence of renal failure. If this
were the case, however, the prevalence of CKD in our cohort
should have been lower than the prevalence of CKD in
unselected cohorts of MI patients. In fact, we observed rates
of stage 3 or higher CKD and a distribution of eGFR that
were strikingly similar to those seen in several recent MI
cohorts.14–16 Although further studies with noninvasive
modalities of coronary imaging will be required to defini-
tively rule out significant confounding from referral bias, we
believe that differential referral patterns are unlikely to fully
explain our findings.
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Figure 3 | Cumulative frequency distribution of infarct location according to CKD status and vessel. (a) Left anterior descending
artery, (b) left circumflex artery, (c) right coronary artery.
Table 5 | Multivariable adjusted predictors of distance to
lesion
Variable b
Standard
95% CI
Bias-corrected
95% CI P-value
Demographics
Age
40–59 (years)a 5.09 10.43–0.25 10.56–0.38 0.06
Male sex 7.31 2.05–12.58 2.22–12.50 0.01
Medical history
CKD 7.00 –13.39 to –0.61 –13.14 to –0.98 0.03
Infarct characteristics
ST elevation MI 4.57 0.37–9.51 0.81–9.02 0.07
RCAb 10.54 5.14–15.94 4.99–16.43 o0.001
MI, myocardial infarction; CI, confidence interval; CKD, chronic kidney disease; RCA,
right coronary.
Significant and borderline significant predictors of lesion location after adjusting for
age, sex, race, hypertension, smoking history, family history, diabetes, infarct type,
and infarct location.
aCompared to age 60–79 years.
bCompared to LAD infarct.
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How the presence of CKD leads to more proximal culprit
lesions is uncertain. One possibility is that the effects of
arterial calcification,17 hypertension, and metabolic distur-
bances in individuals with CKD alters arterial elasticity and
leads to higher levels of proximal shear stress in patients with
CKD compared to patients without CKD. Over time this
increase in shear stress may contribute to endothelial damage
and lead to more frequent plaque ruptures18 in patients with
CKD. In this respect, the recent observation that outward
remodeling is increased in the proximal coronary arteries of
patients with CKD19 is highly intriguing and may provide a
clue toward the underlying biologic processes in patients
with and without CKD. Further studies of shear stress
forces and plaque biology in the coronary arteries of patients
with and without CKD may provide additional insight into
the mechanisms behind our findings. Differences in these
forces due variations in the shape and size of the LAD, LCX,
and RCA might also explain the apparent differences we
observed in the effect of CKD in the epicardial coronary
arteries.
It is also intriguing that despite the more proximal overall
distribution of coronary occlusions in patients with CKD, the
frequency of CKD among those who presented with STEMI
was lower than it was among patients who presented with
NSTEMI. The DTL was more proximal in patients with CKD
regardless of whether they presented with STEMI or
NSTEMI, and it should be noted that our analysis combined
a STEMI cohort with an equally sized cohort of NSTEMIs,
and thus cannot address the true, relative prevalences of
STEMI vs NSTEMI in the overall population of patients with
or without CKD who present with MI. Nevertheless, prior
observations suggest that patients with advanced CKD
present with NSTEMI more frequently than they present
with STEMI.20 Deficiencies in coronary collateral21 and
myocardial capillary supply,22 a high frequency of electrolyte
abnormalities, and left ventricular hypertrophy23 and a high
prevalence of baseline electrocardiographic abnormalities
such as bundle branch block24 and changes in QRS
intervals25 may explain why STEMI is apparently less
prevalent in patients with CKD despite the more proximal
distribution of MI occlusions. In summary, we found that the
culprit lesions in acute MI are significantly more proximal in
patients with CKD than in those without CKD and that
differences in the spatial distribution of MI are independent
of other medical conditions. Proximal lesion location may be
an important factor in determining the increased risk of MI
as well as the increase risk of post-MI death in patients with
CKD. Additional studies to determine how these findings can
be used clinically are warranted.
MATERIALS AND METHODS
Subjects
Two cohorts of patients who presented to Brigham and Women’s
Hospital with acute MI and who underwent coronary angiography
were retrospectively identified as described previously7 and
combined for the purposes of this analysis. Consecutive patients
presenting with STEMI between 1 January 2001 and 31 August 2002
were identified in the first cohort and patients with NSTEMI
between 1 January 2002 and 1 February 2003 were identified in the
second. Besides MI type, the two cohorts used identical inclusion
and exclusion criteria, data extraction, and methods of subject
identification. All patients were required to meet standardized
definitions of MI. STEMI was confirmed when chest pain was
accompanied by ST elevation of at least 1 mm in two contiguous
leads on a surface electrocardiogram. For NSTEMI, symptoms
consistent with acute coronary ischemia, such as chest pain or
dyspnea, had to be present and accompanied by ischemic
electrocardiographic changes (other than ST elevation in two
contiguous leads), elevation in cardiac troponin, or elevation in
creatinine kinase.
Within this cohort, individuals with a history of coronary artery
bypass grafting, cardiac transplant, or a history angioplasty within
the previous 30 days were excluded. In the remaining patients
angiograms were reviewed. Individuals in whom a clear culprit
lesion could not be identified, those with evidence of in-stent-
thrombosis, and those with inadequate angiographic views for
quantitative coronary angiography were excluded from further
analysis. A total of 408 patients met inclusion criteria. In 27 patients,
there was insufficient data to estimate glomerular filtration rate,
leaving 381 individuals for the final analysis.
Table 6 | Adjusted association of CKD stage and distance to lesion
CKD Class b 95% CI P-value
eGFR estimated from creatinine at time of angiography
No CKD/class 1 Referent Referent Referent
Class 2 0.51 6.07–5.04 0.86
Class 3 6.64 14.51–1.22 0.10
Class 4/5 10.83 24.63–2.97 0.12
eGFR estimated from alternative serum creatininea
No CKD/class 1 Referent Referent Referent
Class 2 0.73 5.34–6.80 0.81
Class 3 4.83 14.14–4.48 0.31
Class 4/5 13.69 27.06–0.32 0.05
Abbreviations: eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.
Adjusted association of CKD stage and lesion location after adjusting for age, sex, race, hypertension, smoking history, family history, diabetes, infarct type, and infarct
location.
aSerum creatinine drawn 1–2 days before angiography or, if not available, the serum creatinine drawn on the day of discharge.
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Clinical variables
Medical records were reviewed to collect baseline demographics,
baseline laboratory data, and information on comorbid medical
conditions including diabetes, hypertension, hyperlipidemia, smok-
ing, family history of MI, and prior history of MI. The peak
creatinine kinase and troponin levels reached during the hospita-
lization were recorded as was the serum creatinine drawn at the time
of angiography. eGFR was estimated using the abbreviated
modification of diet in renal disease equation.26 CKD was defined
as an eGFRo60 ml/min per 1.73m2 (equivalent to stage 3 or higher
CKD) for the primary analysis. In a secondary analyses, CKD was
defined according to the National Kidney Foundation guidelines:
class 1/no CKD-eGFR490 ml/min per 1.73 m2; class 2 eGFR
60–89 ml/min per 1.73 m2; class 3 eGFR 30–59 ml/min per 1.73 m2;
class 4/5 eGFR o30 ml/min per 1.73 m2.27 Sensitivity of the overall
results to the choice of serum creatinine was assessed by substituting
a serum creatinine drawn 1–2 days before angiography or, if not
available, the serum creatinine drawn on the day of discharge.
Angiographic analysis
Quantitative coronary angiographic analysis was performed by a
single reader blinded to renal function using a standard software
package (Cardiology Medis System, version 5.1, Nuenen, the
Netherlands). Coronary dimensions were measured following
calibration against catheter dimensions using standard techniques.28
Coronary segments were defined with minor modifications accord-
ing to the coronary artery maps from the Bypass Angioplasty
Revascularization Investigation29 and Coronary Artery Surgery
Study.30 For each segment, standardized angiographic projections
(Table 1) were used to minimize foreshortening and variability in
measurements as described previously.7
The lesion responsible for the MI was identified as the site of
significant stenosis or occlusion. In the event that more than one
potential culprit lesion was present, the culprit lesion was assigned
on the basis of the underlying electrocardiographic findings. Lesion
location was defined as the distance from the coronary ostium to the
point of occlusion or, when flow was present, as the site of the
minimal luminal diameter within the lesion as described pre-
viously.7 The length of each coronary segment was measured in
millimeters and distance to lesion was defined as the sum of the
intervening segment lengths between the coronary ostium and the
acute lesion. The DTL was measured from the left main ostium (left-
sided lesions) or the right coronary ostium (right-sided lesions). A
secondary analysis (vessel analysis) excluded left main lesions and
measured DTL from the ostia of the RCA, LCX or LAD artery,
respectively.
Statistical analysis
Continuous variables are reported as mean±standard deviation
(s.d.), or median and interquartile range if non-normally distrib-
uted. Binary variables are reported as counts (%). Cumulative
density functions and histograms were constructed and graphical
representations of cumulative frequencies of DTL in 10 mm
increments were used to compare the distribution of DTL in
patients with and without CKD. Student’s T-tests and Mann–Whitney
tests were used to compare continuous variables and w2-tests
were used to compare categorical variables. Multivariable linear
regression models were constructed to assess for independence of
the association of CKD with DTL after adjusting for baseline
characteristics. Age, sex, race, diabetes, hypertension, smoking,
hyperlipidemia, and infarct vessel were pre-specified for inclusion
because of the well-described associations of these variables with
cardiovascular outcomes. Additional baseline variables that were
associated with DTL at Po0.10 were included in the multivariable
models. Sensitivity of the regression coefficients to sampling
characteristics was analyzed with bootstrap resampling.31 A total
of 1000 samples were generated with replacement from the original
dataset. Bias-corrected 95% CIs were generated for comparison with
standard 95% CIs. All analyses were performed in STATA version 9.0
(STATA Corporation, College Station, TX, USA). A two-sided
P-value of o0.05 was considered statistically significant.
DISCLOSURE
All the authors declared no competing interests.
ACKNOWLEDGMENTS
Dr Charytan is supported by a 2006, Norman S Coplon grant from
Satellite Health Care.
REFERENCES
1. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of
death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:
1296–1305.
2. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal
dysfunction and cardiovascular outcomes after myocardial infarction.
N Engl J Med 2004; 351: 1285–1295.
3. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis.
Hypertension 2005; 45: 1042–1049.
4. Roberts MA, Hare DL, Ratnaike S et al. Cardiovascular biomarkers in CKD:
pathophysiology and implications for clinical management of cardiac
disease. Am J Kidney Dis 2006; 48: 341–360.
5. Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein
structure and function and microinflammation on cardiovascular risk in
patients with minor renal dysfunction. J Am Soc Nephrol 2004; 15:
538–548.
6. Gibson CM, Kirtane AJ, Murphy SA et al. Distance from the coronary
ostium to the culprit lesion in acute ST-elevation myocardial infarction
and its implications regarding the potential prevention of proximal
plaque rupture. J Thromb Thrombolysis 2003; 15: 189–196.
7. Wang JC, Normand SL, Mauri L et al. Coronary artery spatial distribution
of acute myocardial infarction occlusions. Circulation 2004; 110: 278–284.
8. Mikkelsson J, Eskola M, Nikus K et al. Fatality of myocardial infarction in
relation to the coronary anatomy: role of culprit lesion location. Ann Med
2004; 36: 474–479.
9. Karha J, Murphy SA, Kirtane AJ et al. Evaluation of the association of
proximal coronary culprit artery lesion location with clinical outcomes in
acute myocardial infarction. Am J Cardiol 2003; 92: 913–918.
10. Harjai KJ, Mehta RH, Stone GW et al. Does proximal location of culprit
lesion confer worse prognosis in patients undergoing primary
percutaneous coronary intervention for ST elevation myocardial
infarction? J Interv Cardiol 2006; 19: 285–294.
11. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2
diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353:
238–248.
12. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney
disease from clinical trials in coronary artery disease. Kidney Int 2006; 70:
2021–2030.
13. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of
the serum creatinine assay as critical elements of using equations to
estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920–929.
14. Chew DP, Amerena J, Coverdale S et al. Current management of acute
coronary syndromes in Australia: observations from the acute coronary
syndromes prospective audit. Intern Med J 2007; 37: 741–748.
15. Setoguchi S, Glynn RJ, Avorn J et al. Improvements in long-term mortality
after myocardial infarction and increased use of cardiovascular drugs
after discharge: a 10-year trend analysis. J Am Coll Cardiol 2008; 51:
1247–1254.
16. Bradley EH, Herrin J, Wang Y et al. Racial and ethnic differences in time to
acute reperfusion therapy for patients hospitalized with myocardial
infarction. JAMA 2004; 292: 1563–1572.
17. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult
hemodialysis patients. A link between end-stage renal disease and
cardiovascular disease? J Am Coll Cardiol 2002; 39: 695–701.
86 Kidney International (2009) 75, 80–87
o r i g i n a l a r t i c l e DM Charytan et al.: Proximal location of MI in CKD
18. Slager CJ, Wentzel JJ, Gijsen FJ et al. The role of shear stress in the
destabilization of vulnerable plaques and related therapeutic
implications. Nat Clin Pract Cardiovasc Med 2005; 2: 456–464.
19. Gross ML, Meyer HP, Ziebart H et al. Calcfication of coronary intima and
media: immunohistochemistry, backscatter imagin, and X-ray anlaysis in
renal and nonrenal patients. Clin J AM Soc Nephrol 2007; 2: 121–134.
20. Herzog CA, Littrell K, Arko C et al. Clinical characteristics of dialysis
patients with acute myocardial infarction in the United States: a
collaborative project of the United States Renal Data System and the
National Registry of Myocardial Infarction. Circulation 2007; 116:
1465–1472.
21. Sezer M, Ozcan M, Okcular I et al. A potential evidence to explain the
reason behind the devastating prognosis of coronary artery disease in
uraemic patients: renal insufficiency is associated with poor coronary
collateral vessel development. Int J Cardiol 2007; 115: 366–372.
22. Amann K, Buzello M, Simonaviciene A et al. Capillary/myocyte mismatch
in the heart in renal failure—a role for erythropoietin? Nephrol Dial
Transplant 2000; 15: 964–969.
23. Shlipak MG, Fried LF, Cushman M et al. Cardiovascular mortality risk in
chronic kidney disease: comparison of traditional and novel risk factors.
JAMA 2005; 293: 1737–1745.
24. McCullough PA, Hassan SA, Pallekonda V et al. Bundle branch block
patterns, age, renal dysfunction, and heart failure mortality. Int J Cardiol
2005; 102: 303–308.
25. Kestenbaum B, Rudser KD, Shlipak MG et al. Kidney function,
electrocardiographic findings, and cardiovascular events among older
adults. Clin J Am Soc Nephrol 2007; 2: 501–508.
26. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine
values in the modification of diet in renal disease study equation for
estimating glomerular filtration rate. Ann Intern Med 2006; 145:
247–254.
27. Reilly RF, Perazella MA. Chronic kidney disease: a new approach to an old
problem. Conn Med 2002; 66: 579–583.
28. Reiber JH, Jukema W, van Boven A et al. Catheter sizes for quantitative
coronary arteriography. Cathet Cardiovasc Diagn 1994; 33: 153–155;
discussion 156.
29. Alderman EL, Stadius M. The angiographic definitions of the Bypass
Angioplasty Revascularization Investigation. Coron Artery Dis 1992; 3:
1189–1207.
30. Killip T, Fisher L, Mock M. National Heart, Lung, and Blood Institute
Coronary Artery Surgery Study. A multicenter comparison of the effects
of randomized medical and surgical treatment of mildly symptomatic
patients with coronary artery disease, and a registry of consecutive
patients undergoing coronary angiography. Circulation 1981; 63:
I1–81.
31. Schumacher M, Hollander N, Sauerbrei W. Resampling and cross-
validation techniques: a tool to reduce bias caused by model building?
Stat Med 1997; 16: 2813–2827.
Kidney International (2009) 75, 80–87 87
DM Charytan et al.: Proximal location of MI in CKD o r i g i n a l a r t i c l e
